申请人:Cheng Hengmiao
公开号:US20050148631A1
公开(公告)日:2005-07-07
The present invention relates to compounds with the formula (I), or a pharmaceutically acceptable salt thereof:
The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) or formula (II) and methods of treating a condition that is mediated by the modulation of 11-β-hsd-1, the method comprising administering to a mammal an effective amount of a compound of formula (I) or formula (II).
本发明涉及具有化学式(I)或其药学上可接受的盐的化合物:该发明还涉及包含化学式(I)或化学式(II)化合物的药物组合物,以及治疗通过调节11-β-hsd-1介导的疾病的方法,该方法包括向哺乳动物施用化学式(I)或化学式(II)化合物的有效量。